Weight loss drug shows remarkable results for reducing diabetes risk
Eli Lilly’s weight loss drug, tirzepatide, has shown remarkable results in reducing the risk of Type 2 diabetes by 94% for overweight individuals, based on...
Click Here to access the online Public Inspection File
Viewers with disabilities can get assistance accessing this station’s FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC’s online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or fccinfo@fcc.gov.
Public File Liaison:
publicfilessbn@federatedmedia.com
574-258-5483
